Product
CST-103
Aliases
CST-103, CST-107, matching placebo
2 clinical trials
5 indications
Indication
Parkinson's DiseaseIndication
Parkinson's Disease DementiaIndication
Mild Cognitive ImpairmentIndication
Lewy Body DementiaClinical trial
A Phase II, Randomized, Placebo-Controlled, Double-Blind, Crossover Study to Evaluate the Use of CST-103 Co-administered With CST-107 on Freezing of Gait in Subjects With Parkinson's DiseaseStatus: Not yet recruiting, Estimated PCD: 2024-12-01
Clinical trial
A Phase II, Randomized, Placebo-Controlled, Double-Blind, Crossover, Study of the Pharmacodynamic Effects of CST-103 Co-administered With CST-107 on the Central Nervous System in Subjects With Neurodegenerative DisordersStatus: Active (not recruiting), Estimated PCD: 2022-07-04